Table 1 Laboratory assessment of included patients
From: Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
Group I (N = 30) | Group II (N = 30) | Group III (N = 30) | Group IV (N = 30) | p-value | |
|---|---|---|---|---|---|
HbA1c | 5.8 ± 0.2 | 6.1 ± 0.4 | 9.3 ± 0.7 | 9.6 ± 1 | p2, p3, p4, p5, < 0.05 p1, p6 > 0.05 |
FBS | 104 ± 6.2 | 110 ± 8.5 | 252.6 ± 42 | 271.3 ± 53.1 | p1 = 0.6 p2, p3, p4, p5, p6 = 0.05 |
Hemoglobin | 12.83 ± 0.46 | 12.86 ± 0.49 | 12.82 ± 0.5 | 12.59 ± 0.49 | 0.29 |
Hematocrit | 39.1 ± 0.7 | 42.2 ± 2.5 | 39.5 ± 1.0 | 42.4 ± 2.0 | p2, p5 > 0.05 p1, p3, p4, p6 = 0.05 |
Platelets | 219.7 ± 14.6 | 256.9 ± 19.5 | 211 ± 22.1 | 213.3 ± 21.1 | p2, p3, p6 > 0.05 p1, p4, p5 < 0.05 |
Leukocytes | 7.8 ± 1.5 | 8.5 ± 1.4 | 8.1 ± 1.3 | 9.3 ± 1.1 | p2, p4 > 0.05 p1, p3, p5, p6 < 0.05 |
Neutrophil | 3.6 ± 0.6 | 4.6 ± 1.9 | 4.4 ± 1.3 | 6.5 ± 1.6 | p4 > 0.05 p1, p2, p3, p5, p6 < 0.05 |
Lymphocyte | 2.0 ± 0.4 | 1.9 ± 1.0 | 2.1 ± 0.6 | 1.7 ± 0.6 | 0.215 |
PLR | 119 ± 33.2 | 150.2 ± 38.6 | 107.3 ± 33.8 | 140.7 ± 58 | p1, p3, p4, p5, p6 < 0.05 p2 > 0.05 |
NLR | 2.0 ± 0.6 | 2.6 ± 1.3 | 2.3 ± 1.1 | 4.3 ± 2.1 | p3, p5, p6 < 0.05 p1, p2, p4 > 0.05 |
CRP | 4.2 ± 0.9 | 7.8 ± 1.1 | 4.2 ± 1.6 | 7.9 ± 1.1 | p1, p3, p4, p6 < 0.05 p2 > 0.05 |